The ACRONYM (Alternatives for Circumvention of Restrictions on Naming BY Trialists of Their Manuscripts) Report

Journal of Medical Humanities 30 (2):131-133 (2009)
  Copy   BIBTEX

Abstract

It is hoped that this commentary may draw attention to the issues raised by the enthusiastic naming of large clinical trials. Although the article is tongue in cheek, the underlying concern is that the names of studies may not, in fact, correspond to the actual results they yield

Categories

Keywords

Reprint years

DOI

10.1007/s10912-009-9076-6

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,423

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Characterizing the Population in Clinical Trials: Barriers, Comparability, and Implications for Review.Charles Weijer - unknown
Assay Sensitivity and the Epistemic Contexts of Clinical Trials.Spencer Phillips Hey & Charles Weijer - 2013 - Perspectives in Biology and Medicine 56 (1):1-17.
Making light of keeping color categories in the dark: Some arguments against Saunders and Van Brakel's notions of trivial constraints in color nomenclature.James Stanlaw - 1997 - Behavioral and Brain Sciences 20 (2):208-209.
The Duty to Disclose Adverse Clinical Trial Results.S. Matthew Liao, Mark Sheehan & Steve Clarke - 2009 - American Journal of Bioethics 9 (8):24-32.
Naming elements after scientists: An account of a controversy. [REVIEW]Geoff Rayner-Canham & Zheng Zheng - 2007 - Foundations of Chemistry 10 (1):13-18.
Reporting the Study Populations of Clinical Trials. Clear Transmission or Static on the Line?Stanley H. Shapiro, Charles Weijer & Benjamin Freedman - unknown
Allen's Notes on Abbreviations in Greek Manuscripts - Notes on Abbreviations in Greek Manuscripts, by T. W. Allen, Queen's College, Oxford, Craven Fellow. Oxford (Clarendon Press), 1889. 5 s. [REVIEW]E. Maunde Thompson - 1890 - The Classical Review 4 (05):219-220.
Inefficacy Interim Monitoring Procedures in Randomized Clinical Trials: The Need to Report.Boris Freidlin & Edward L. Korn - 2011 - American Journal of Bioethics 11 (3):2-10.
Reporting of informed consent, standard of care and post-trial obligations in global randomized intervention trials: A systematic survey of registered trials.Emma R. M. Cohen, Jennifer M. O'neill, Michel Joffres, Ross E. G. Upshur & Edward Mills - 2008 - Developing World Bioethics 9 (2):74-80.
Statistical Power, the Belmont Report, and the Ethics of Clinical Trials.Sara H. Vollmer & George Howard - 2010 - Science and Engineering Ethics 16 (4):675-691.
The use of interval estimators as a basis for decision-making in medicine.Reidar K. Lie - 1984 - Theoretical Medicine and Bioethics 5 (3).
The Breast Cancer Research Scandal: Addressing the Issues.Charles Weijer - unknown
Ethical Considerations for Outcome‐adaptive Trial Designs: A Clinical Researcher's Perspective.Scott Brian Saxman - 2014 - Bioethics 29 (2):59-65.

Analytics

Added to PP
2013-11-24

Downloads
19 (#783,934)

6 months
7 (#416,569)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references